世界中の市場調査レポートを販売！当社に無いレポートもお探しします。

レポートナンバー　0000031856

医薬品原料・製剤
アウトソーシング

ワクチン製造受託市場レポート2022-2032

Visiongain

Vaccine Contract Manufacturing Market Report 2022-2032

発刊日 2022/04/13

言語英語

体裁PDF/565ページ

ライセンス/価格565ページ

0000031856

Single - 1 Year License
(Team License - Up to 6 Users) - 1 Year License
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス（ライセンス期間1年、ユーザー数5人）をご検討ください。
※詳しくはお問い合わせください。

お問い合わせ
サンプル依頼

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

プロセス別予測（上流プロセス、下流プロセス）、下流別（充填および仕上げ操作、分析およびQC研究、ワクチン包装）、上流別（哺乳類発現ワクチン、細菌発現ワクチン、酵母発現ワクチン、バキュロウイルス/昆虫発現ワクチン、その他）による予測）、タイプ別（サブユニットワクチン、弱毒生ワクチン、複合ワクチン、不活化ワクチン、組換えベクターワクチン、その他）、会社規模別（小規模メーカー、中規模メーカー、大規模メーカー、超大規模メーカー）、運用別（前臨床、臨床、商業、その他）および地域および主要国別市場分析に加えて主要企業の分、および COVID-19 回復シナリオ

実用化までの時間の短縮、インフラコストのメリット、運用上のメリットなどが市場の成長を促進

世界のワクチン製造受託市場を推進する主な要因としては、実用化までの時間の短縮、インフラコストの削減、運用上のメリットなどがあります。さらに、GPExやEB66細胞株などの新しい発現システムや細胞培養培地プラットフォームの開発などの技術的進歩によって、市場の成長が促進されることが期待されます。一方、アウトソーシングは戦略や経営上の管理ができないため望ましくないと考える大手企業はほとんどありません。供給を拡大またはローカライズしようとしている国の施設、設備、熟練労働者への多額の投資は、受託製造サービスの採用にプラスの影響を与えると予想されます。さらに、低資源国の一部は、ワクチンを製造するために必要な設備や経験豊富な人材が不足していることから、市場の需要を満たすために受託製造事業者に委託するようになっています。

レポート詳細

目次

1. Report Overview
1.1 Introduction to Vaccine Contract Manufacturing Market
1.2 Global Vaccine Contract Manufacturing Market Overview
1.3 What are the Objectives of this Report?
1.4 What is the Scope of the Report?
1.5 Why You Should Read This Report
1.6 What This Report Delivers
1.7 Key Questions Answered By This Analytical Report Include:
1.8 Who is This Report for?
1.9 Research Methodology
1.9.1 Primary Research
1.9.2 Secondary Research
1.9.3 Market Evaluation & Forecasting Methodology
1.10 Frequently Asked Questions (FAQs)
1.11 Associated Visiongain Reports
1.12 About Visiongain

2 Executive Summary

3 Global Market Dynamics
3.1 COVID-19 Impact on Global Market:
3.2 Current Trends in the Global Market
3.3 Market Driving Factors
3.3.1 Growth In Infectious Diseases
3.3.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.3.3 Implications Beyond COVID-19
3.4 Market Restraining Factors
3.4.1 Material And Equipment Shortages
3.4.2 Manufacturing Process Complexity
3.4.3 Capacity Constraints
3.5 Opportunities in the Global Market
3.5.1 New Vaccine Technologies
3.5.1.1 Gene-based vaccines
3.5.1.2 VLPs
3.5.1.3 Plant-derived vaccines
3.5.1.4 Novel adjuvants and delivery systems.
3.6 Challenges in the Global Market
3.6.1 Unprecedented Vaccine Production Demand
3.6.2 Logistical And Administrative Challenges
3.6.3 Vaccine Hesitancy
3.7 SWOT Analysis
3.7.1 Strength
3.7.1.1 Growth In Infectious Diseases
3.7.1.2 Stakeholder Cooperation Maximises Manufacturing Capacity
3.7.1.3 Implications Beyond COVID-19
3.7.2 Weakness
3.7.2.1 Material And Equipment Shortages
3.7.2.2 Manufacturing Process Complexity
3.7.2.3 Capacity Constraints
3.7.3 Opportunities
3.7.3.1 New Vaccine Technologies
3.7.4 Threats
3.7.4.1 Unprecedented Vaccine Production Demand
3.7.4.2 Logistical And Administrative Challenges
3.7.4.3 Vaccine Hesitancy
3.8 PEST Analysis:
3.8.1 Political Factors
3.8.2 Economic Factors
3.8.3 Sociocultural Factors
3.8.4 Technological Factors
3.9 Porter’s Five Forces Analysis
3.9.1 What are Porter Five (5) Forces
3.9.2 Threat of New Entrants (Low to Moderate)
3.9.3 Rivalry Among the Existing Players (High)
3.9.4 Bargaining Power of Suppliers (Low)
3.9.5 Threats from Substitute Products (Low to Moderate)
3.9.6 Bargaining Power of Buyers (High)

4 Global Vaccine Contract Manufacturing Market Analysis
4.1 Global Market Outlook
4.2 Global Market Size Estimation and Forecast
4.2.1 Pre-COVID-19 Market Scenario
4.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

5 Global Vaccine Contract Manufacturing Market Analysis By Region
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 LAMEA
5.5 Regional Market Size Estimation and Forecast
5.5.1 Pre-COVID-19 Market Scenario
5.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

6 Global Vaccine Contract Manufacturing Market Analysis By Process
6.1 Upstream Process
6.2 Downstream Process
6.3 Global Market Size Estimation and Forecast By Process
6.3.1 Pre-COVID-19 Market Scenario
6.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

7 Global Vaccine Contract Manufacturing Market Analysis By Downstream
7.1 Fill & Finish Operations
7.2 Analytical & QC Studies
7.3 Vaccine Packaging
7.4 Global Market Size Estimation and Forecast By Downstream
7.4.1 Pre-COVID-19 Market Scenario
7.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

8 Global Vaccine Contract Manufacturing Market Analysis By Upstream
8.1 Mammalian Expression Vaccine Type
8.2 Bacterial Expression Vaccine Type
8.3 Yeast Expression Vaccine Type
8.4 Baculovirus/Insect Expression Vaccine Type
8.5 Other Upstream Process
8.6 Global Market Size Estimation and Forecast By Upstream
8.6.1 Pre-COVID-19 Market Scenario
8.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

9 Global Vaccine Contract Manufacturing Market Analysis By Vaccine Type
9.1 Subunit Vaccines
9.2 Live Attenuated Vaccines
9.3 Conjugate Vaccines
9.4 Inactivated Vaccines
9.5 Recombinant Vector Vaccines
9.6 Other Vaccine Type
9.7 Global Market Size Estimation and Forecast By Vaccine Type
9.7.1 Pre-COVID-19 Market Scenario
9.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

10 Global Vaccine Contract Manufacturing Market Analysis By Company Size
10.1 Global Market Size Estimation and Forecast By Company Size
10.1.1 Pre-COVID-19 Market Scenario
10.1.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

11 Global Vaccine Contract Manufacturing Market Analysis By Operation
11.1 Preclinical
11.2 Clinical
11.3 Commercial
11.4 Global Market Size Estimation and Forecast By Operation
11.4.1 Pre-COVID-19 Market Scenario
11.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

12 North America Vaccine Contract Manufacturing Market Analysis
12.1 North American Countries Have The Most Demanding Legislation Regulating And Controlling Pharmaceuticals’ Distribution And Production
12.2 North America Market Size Estimation and Forecast
12.2.1 Pre-COVID-19 Market Scenario
12.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.3 Country Market Size Estimation and Forecast
12.3.1 Pre-COVID-19 Market Scenario
12.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.4 North America Market Size Estimation and Forecast By Process
12.4.1 Pre-COVID-19 Market Scenario
12.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.5 North America Market Size Estimation and Forecast By Downstream
12.5.1 Pre-COVID-19 Market Scenario
12.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.6 North America Market Size Estimation and Forecast By Upstream
12.6.1 Pre-COVID-19 Market Scenario
12.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.7 North America Market Size Estimation and Forecast By Vaccine Type
12.7.1 Pre-COVID-19 Market Scenario
12.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.8 North America Market Size Estimation and Forecast By Company Size
12.8.1 Pre-COVID-19 Market Scenario
12.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.9 North America Market Size Estimation and Forecast By Operation
12.9.1 Pre-COVID-19 Market Scenario
12.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.10 US Vaccine Contract Manufacturing Market Analysis
12.10.1 Collaboration Between GSK and Vir Biotechnology to Purchase Additional Supply of Sotrovimab
12.10.2 Pre-COVID-19 Market Scenario
12.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.11 Canada Vaccine Contract Manufacturing Market Analysis
12.11.1 Emergent Biosolutions Secures Multi-Year Development And Manufacturing Agreement With Providence Therapeutics For Its Mrna COVID-19 Vaccine Candidate, PTX-COVID19-B
12.11.2 Pre-COVID-19 Market Scenario
12.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
12.12 Mexico Vaccine Contract Manufacturing Market Analysis
12.12.1 First COVID-19 Vaccine Fill-Finish Manufacturing In Mexico Completed
12.12.2 Pre-COVID-19 Market Scenario
12.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

13 Europe Vaccine Contract Manufacturing Market Analysis
13.1 EU Watchdog Okays Production Capacity Hikes For J&J, Moderna, Pfizer Vaccines
13.2 European Commission Approves Contract With Valneva To Secure A New Potential Vaccine
13.3 Europe Market Size Estimation and Forecast
13.3.1 Pre-COVID-19 Market Scenario
13.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.4 Country Market Size Estimation and Forecast
13.4.1 Pre-COVID-19 Market Scenario
13.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.5 Europe Market Size Estimation and Forecast By Process
13.5.1 Pre-COVID-19 Market Scenario
13.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.6 Europe Market Size Estimation and Forecast By Downstream
13.6.1 Pre-COVID-19 Market Scenario
13.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.7 Europe Market Size Estimation and Forecast By Upstream
13.7.1 Pre-COVID-19 Market Scenario
13.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.8 Europe Market Size Estimation and Forecast By Vaccine Type
13.8.1 Pre-COVID-19 Market Scenario
13.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.9 Europe Market Size Estimation and Forecast By Company Size
13.9.1 Pre-COVID-19 Market Scenario
13.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.10 Europe Market Size Estimation and Forecast By Operation
13.10.1 Pre-COVID-19 Market Scenario
13.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.11 Germany Vaccine Contract Manufacturing Market Analysis
13.11.1 Curevac Slashes COVID-19 Vaccine Production Plans
13.11.2 Pre-COVID-19 Market Scenario
13.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.12 UK Vaccine Contract Manufacturing Market Analysis
13.12.1 UK Reportedly Selling £200m Vaccine Plant That Never Produced A Single Dose
13.12.2 Pre-COVID-19 Market Scenario
13.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.13 France Vaccine Contract Manufacturing Market Analysis
13.13.1 Recipharm Secures Vaccine Manufacturing Deal With Top 10 Big Pharma And Will Provide Manufacturing Support From Facility In Kaysersberg, France
13.13.2 Pre-COVID-19 Market Scenario
13.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.14 Italy Vaccine Contract Manufacturing Market Analysis
13.14.1 Aenova’s Biologics And Vaccines Manufacturing Facility Expansion, Latina, Italy
13.14.2 Pre-COVID-19 Market Scenario
13.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.15 Spain Vaccine Contract Manufacturing Market Analysis
13.15.1 Moderna And ROVI Expand Long-Term Collaboration For The Manufacture Of MRNA Medicines Over The Next Ten Years
13.15.2 Pre-COVID-19 Market Scenario
13.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
13.16 Rest of Europe Vaccine Contract Manufacturing Market Analysis
13.16.1 Pre-COVID-19 Market Scenario
13.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

14 Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.1 Asia Pacific Must Fix Its Broken Vaccine System
14.2 Asia-Pacific Market Size Estimation and Forecast
14.2.1 Pre-COVID-19 Market Scenario
14.2.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.3 Country Market Size Estimation and Forecast
14.3.1 Pre-COVID-19 Market Scenario
14.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.4 Asia-Pacific Market Size Estimation and Forecast By Process
14.4.1 Pre-COVID-19 Market Scenario
14.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.5 Asia-Pacific Market Size Estimation and Forecast By Downstream
14.5.1 Pre-COVID-19 Market Scenario
14.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.6 Asia-Pacific Market Size Estimation and Forecast By Upstream
14.6.1 Pre-COVID-19 Market Scenario
14.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.7 Asia-Pacific Market Size Estimation and Forecast By Vaccine Type
14.7.1 Pre-COVID-19 Market Scenario
14.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.8 Asia-Pacific Market Size Estimation and Forecast By Company Size
14.8.1 Pre-COVID-19 Market Scenario
14.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.9 Asia-Pacific Market Size Estimation and Forecast By Operation
14.9.1 Pre-COVID-19 Market Scenario
14.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.10 China Vaccine Contract Manufacturing Market Analysis
14.10.1 China Is Manufacturing Vaccines In Africa.
14.10.2 Pre-COVID-19 Market Scenario
14.10.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.11 India Vaccine Contract Manufacturing Market Analysis
14.11.1 Serum Institute Invests $68m In Oxford Biomedica To Expand Vector Capacity
14.11.2 Pre-COVID-19 Market Scenario
14.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.12 Japan Vaccine Contract Manufacturing Market Analysis
14.12.1 Japan's Takara Bio To Launch Contract Production Of Mrna Vaccines
14.12.2 Pre-COVID-19 Market Scenario
14.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.13 South Korea Vaccine Contract Manufacturing Market Analysis
14.13.1 Moderna, Novavax To Produce More COVID-19 Vaccines In South Korea
14.13.2 South Korea’s SK Bioscience Expands Manufacturing Agreement For Novavax’s COVID-19 Vaccine
14.13.3 Pre-COVID-19 Market Scenario
14.13.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.14 Australia Vaccine Contract Manufacturing Market Analysis
14.14.1 Novavax Hunts For Australian Manufacturer As CSL Homes In On AstraZeneca Vaccine Production
14.14.2 Australia Plans To Stop AstraZeneca Vaccine Production
14.14.3 Pre-COVID-19 Market Scenario
14.14.4 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
14.15 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Analysis
14.15.1 Pre-COVID-19 Market Scenario
14.15.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

15 LAMEA Vaccine Contract Manufacturing Market Analysis
15.1 PAHO Welcomes First WHO Emergency Use Listing Of COVID-19 Vaccine Produced In Latin America
15.2 Brazil And Argentina Tapped To Make mRNA Vaccines In Latin America
15.3 LAMEA Market Size Estimation and Forecast
15.3.1 Pre-COVID-19 Market Scenario
15.3.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.4 Country Market Size Estimation and Forecast
15.4.1 Pre-COVID-19 Market Scenario
15.4.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.5 LAMEA Market Size Estimation and Forecast By Process
15.5.1 Pre-COVID-19 Market Scenario
15.5.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.6 LAMEA Market Size Estimation and Forecast By Downstream
15.6.1 Pre-COVID-19 Market Scenario
15.6.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.7 LAMEA Market Size Estimation and Forecast By Upstream
15.7.1 Pre-COVID-19 Market Scenario
15.7.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.8 LAMEA Market Size Estimation and Forecast By Vaccine Type
15.8.1 Pre-COVID-19 Market Scenario
15.8.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.9 LAMEA Market Size Estimation and Forecast By Company Size
15.9.1 Pre-COVID-19 Market Scenario
15.9.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.10 LAMEA Market Size Estimation and Forecast By Operation
15.10.1 Pre-COVID-19 Market Scenario
15.10.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.11 Brazil Vaccine Contract Manufacturing Market Analysis
15.11.1 Pfizer, Biontech Sign On With Eurofarma Of Brazil For COVID-19 Vaccine Production
15.11.2 Pre-COVID-19 Market Scenario
15.11.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.12 South Africa Vaccine Contract Manufacturing Market Analysis
15.12.1 Janssen And Aspen Enter Deal To Manufacture Covid-19 Vaccine In Africa
15.12.2 Pre-COVID-19 Market Scenario
15.12.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.13 Saudi Arabia Vaccine Contract Manufacturing Market Analysis
15.13.1 Saudi Arabia Agrees Deal With GSK To Develop Healthcare Sector
15.13.2 Pre-COVID-19 Market Scenario
15.13.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.14 Turkey Vaccine Contract Manufacturing Market Analysis
15.14.1 Turkey Renews SK Bioscience’s Vaccine Manufacturing Certification
15.14.2 Pre-COVID-19 Market Scenario
15.14.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.15 UAE Vaccine Contract Manufacturing Market Analysis
15.15.1 Mubadala, G42 To Set Up Biopharma Manufacturing Campus In Abu Dhabi
15.15.2 Pre-COVID-19 Market Scenario
15.15.3 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)
15.16 Rest of LAMEA Vaccine Contract Manufacturing Market Analysis
15.16.1 Pre-COVID-19 Market Scenario
15.16.2 Post-COVID-19 Market Scenarios (V, W, U, L-Shaped Recovery Analysis)

16 Company Profiles
16.1 Catalent
16.1.1 Company Snapshot
16.1.2 Company Overview
16.1.3 Company Financial Profile
16.1.4 Company Product/Service Benchmarking
16.1.5 Company Recent Developments
16.2 Emergent BioSolutions
16.2.1 Company Snapshot
16.2.2 Company Overview
16.2.3 Company Financial Profile
16.2.4 Company Product/Service Benchmarking
16.2.5 Company Recent Developments
16.3 GlaxoSmithKline
16.3.1 Company Snapshot
16.3.2 Company Overview
16.3.3 Company Financial Profile
16.3.4 Company Product/Service Benchmarking
16.3.5 Company Recent Developments
16.4 Lonza Group AG
16.4.1 Company Snapshot
16.4.2 Company Overview
16.4.3 Company Financial Profile
16.4.4 Company Product/Service Benchmarking
16.4.5 Company Recent Developments
16.5 Merck KGaA
16.5.1 Company Snapshot
16.5.2 Company Overview
16.5.3 Company Financial Profile
16.5.4 Company Product/Service Benchmarking
16.5.5 Company Recent Developments
16.6 Pfizer
16.6.1 Company Snapshot
16.6.2 Company Overview
16.6.3 Company Financial Profile
16.6.4 Company Product/Service Benchmarking
16.6.5 Company Recent Developments
16.7 Siegfried Holding
16.7.1 Company Snapshot
16.7.2 Company Overview
16.7.3 Company Financial Profile
16.7.4 Company Product/Service Benchmarking
16.7.5 Company Recent Developments
16.8 Sanofi
16.8.1 Company Snapshot
16.8.2 Company Overview
16.8.3 Company Financial Profile
16.8.4 Company Product/Service Benchmarking
16.9 Bavarian Nordic
16.9.1 Company Snapshot
16.9.2 Company Overview
16.9.3 Company Financial Profile
16.9.4 Company Product/Service Benchmarking
16.10 FUJIFILM Holdings Corp
16.10.1 Company Snapshot
16.10.2 Company Overview
16.10.3 Company Financial Profile
16.10.1 Company Product/Service Benchmarking
16.11 Charles River Laboratories
16.11.1 Company Snapshot
16.11.2 Company Overview
16.11.3 Company Financial Profile
16.11.4 Company Product/Service Benchmarking
16.11.5 Company Recent Developments
16.12 Samsung Biologics
16.12.1 Company Snapshot
16.12.2 Company Overview
16.12.3 Company Financial Profile
16.12.4 Company Product/Service Benchmarking
16.12.5 Company Recent Developments
16.13 AbbVie
16.13.1 Company Snapshot
16.13.2 Company Overview
16.13.3 Company Financial Profile
16.13.4 Company Product/Service Benchmarking
16.14 Thermo Fisher Scientific Inc
16.14.1 Company Snapshot
16.14.2 Company Overview
16.14.3 Company Financial Profile
16.14.4 Company Product/Service Benchmarking
16.14.5 Company Recent Developments
16.15 Eurofins Scientific
16.15.1 Company Snapshot
16.15.2 Company Overview
16.15.3 Company Financial Profile
16.15.4 Company Product/Service Benchmarking
16.15.5 Company Recent Developments
16.16 WuXi Biologics
16.16.1 Company Snapshot
16.16.2 Company Overview
16.16.3 Company Financial Profile
16.16.4 Company Product/Service Benchmarking
16.16.5 Company Recent Developments
16.17 Serum Institute of India
16.17.1 Company Snapshot
16.17.2 Company Overview
16.17.3 Company Product/Service Benchmarking
16.17.4 Company Recent Developments
16.18 Richter-Helm BioLogics
16.18.1 Company Snapshot
16.18.2 Company Overview
16.18.3 Company Product/Service Benchmarking
16.18.4 Company Recent Developments
16.19 Wacker Biotech B.V
16.19.1 Company Snapshot
16.19.2 Company Overview
16.19.3 Company Product/Service Benchmarking
16.20 Kemwell Biopharma
16.20.1 Company Snapshot
16.20.2 Company Overview
16.20.3 Company Product/Service Benchmarking

17 Conclusion
17.1 Concluding Remarks
17.2 Recommendations

目次(続き）

List of Tables
Table 1. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 2. Global Vaccine Contract Manufacturing Market Snapshot, 2022 & 2032 (US$million, CAGR %)
Table 3. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 4. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 5. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 6. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 7. Global Vaccine Contract Manufacturing Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 8. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 9. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 10. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 11. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 12. Global Vaccine Contract Manufacturing Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 13. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 14. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 15. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 16. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 17. Global Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 18. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 19. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 20. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 21. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 22. Global Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 23. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 24. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 25. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 26. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 27. Global Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 28. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 29. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 30. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 31. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 32. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 33. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 34. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 35. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 36. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 37. Global Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 38. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 39. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 40. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 41. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 42. Global Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 43. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 44. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 45. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 46. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 47. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 48. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 49. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 50. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 51. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 52. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 53. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 54. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 55. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 56. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 57. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 58. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 59. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 60. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 61. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 62. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 63. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 64. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 65. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 66. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 67. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 68. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 69. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 70. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 71. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 72. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 73. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 74. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 75. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 76. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 77. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 78. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 79. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 80. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 81. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 82. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 83. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 84. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 85. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 86. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 87. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 88. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 89. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 90. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 91. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 92. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 93. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 94. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 95. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 96. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 97. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 98. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 99. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 100. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 101. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 102. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 103. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 104. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 105. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 106. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 107. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 108. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 109. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 110. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 111. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 112. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 113. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 114. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 115. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 116. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 117. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 118. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 119. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 120. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 121. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 122. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 123. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 124. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 125. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 126. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 127. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 128. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 129. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 130. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 131. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 132. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 133. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 134. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 135. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 136. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 137. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 138. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 139. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 140. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 141. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 142. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 143. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 144. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 145. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 146. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 147. UK Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 148. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 149. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 150. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 151. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 152. France Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 153. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 154. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 155. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 156. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 157. Italy Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 158. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 159. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 160. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 161. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 162. Spain Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 163. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 164. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 165. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 166. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 167. Rest of Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 168. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 169. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 170. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 171. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 172. Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 173. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 174. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 175. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 176. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 177. Asia-Pacific Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 178. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 179. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 180. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 181. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 182. Asia-Pacific Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 183. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 184. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 185. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 186. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 187. Asia-Pacific Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 188. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 189. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 190. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 191. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 192. Asia-Pacific Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 193. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 194. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 195. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 196. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 197. Asia-Pacific Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 198. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 199. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 200. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 201. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 202. Asia-Pacific Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 203. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 204. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 205. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 206. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 207. Asia-Pacific Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 208. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 209. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 210. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 211. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 212. China Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 213. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 214. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 215. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 216. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 217. India Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 218. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 219. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 220. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 221. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 222. Japan Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 223. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 224. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 225. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 226. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 227. South Korea Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 228. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 229. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 230. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 231. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 232. Australia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 233. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 234. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 235. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 236. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 237. Rest of Asia-Pacific Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 238. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 239. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 240. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 241. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 242. LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 243. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 244. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 245. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 246. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 247. LAMEA Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 248. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 249. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 250. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 251. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 252. LAMEA Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 253. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 254. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 255. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 256. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 257. LAMEA Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 258. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 259. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 260. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 261. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 262. LAMEA Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 263. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 264. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 265. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 266. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 267. LAMEA Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 268. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 269. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 270. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 271. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 272. LAMEA Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 273. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 274. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 275. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 276. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 277. LAMEA Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 278. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 279. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 280. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 281. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 282. Brazil Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 283. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 284. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 285. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 286. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 287. South Africa Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 288. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 289. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 290. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 291. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 292. Saudi Arabia Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 293. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 294. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 295. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 296. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 297. Turkey Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 298. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 299. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 300. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 301. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 302. UAE Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 303. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
Table 304. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Table 305. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Table 306. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Table 307. Rest of LAMEA Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Table 308. Catalent: Company Information
Table 309. Catalent: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 310. Catalent: Company Product and Service Benchmarking
Table 311. Catalent: Company Recent Developments till Feb,2021
Table 312. Emergent BioSolutions: Company Information
Table 313. Emergent BioSolutions: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 314. Emergent BioSolutions: Company Product and Service Benchmarking
Table 315. Emergent BioSolutions: Company Recent Developments
Table 316. GlaxoSmithKline: Company Information
Table 317. GlaxoSmithKline: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 318. GlaxoSmithKline: Company Product and Service Benchmarking
Table 319. GlaxoSmithKline: Company Recent Developments
Table 320. Lonza Group AG: Company Information
Table 321. Lonza Group AG: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 322. Lonza Group AG : Company Product and Service Benchmarking
Table 323. Lonza Group AG: Company Recent Developments till Feb,2021
Table 324. Merck KGaA: Company Information
Table 325. Merck KGaA: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 326. Merck KGaA: Company Product and Service Benchmarking
Table 327. Merck KGaA: Company Recent Developments
Table 328. Pfizer: Company Information
Table 329. Pfizer: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 330. Pfizer: Company Product and Service Benchmarking
Table 331. Pfizer: Company Recent Developments
Table 332. Siegfried Holding: Company Information
Table 333. Siegfried Holding: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 334. Siegfried Holding: Company Product and Service Benchmarking
Table 335. Siegfried Holding: Company Recent Developments till Feb,2021
Table 336. Sanofi: Company Information
Table 337. Sanofi: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 338. Sanofi: Company Product and Service Benchmarking
Table 339. Bavarian Nordic: Company Information
Table 340. Bavarian Nordic: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 341. Bavarian Nordic: Company Product and Service Benchmarking
Table 342. FUJIFILM Holdings Corp: Company Information
Table 343. FUJIFILM Holdings Corp: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 344. FUJIFILM Holdings Corporation : Company Product and Service Benchmarking
Table 345. Charles River Laboratories: Company Information
Table 346. Charles River Laboratories: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 347. Charles River Laboratories: Company Product and Service Benchmarking
Table 348. Charles River Laboratories: Company Recent Developments till Feb,2021
Table 349. Samsung Biologics: Company Information
Table 350. Samsung Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 351. Samsung Biologics: Company Product and Service Benchmarking
Table 352. Samsung Biologics: Company Recent Developments
Table 353. AbbVie: Company Information
Table 354. AbbVie: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 355. AbbVie: Company Product and Service Benchmarking
Table 356. Thermo Fisher Scientific Inc: Company Information
Table 357. Thermo Fisher Scientific Inc: Company Revenue 2017-2021 (US$Mn, AGR %)
Table 358. Thermo Fisher Scientific Inc: Company Product and Service Benchmarking
Table 359. Thermo Fisher Scientific Inc: Company Recent Developments till Feb,2021
Table 360. Eurofins Scientific: Company Information
Table 361. Eurofins Scientific: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 362. Eurofins Scientific: Company Product and Service Benchmarking
Table 363. Eurofins Scientific: Company Recent Developments
Table 364. WuXi Biologics: Company Information
Table 365. WuXi Biologics: Company Revenue 2016-2020 (US$Mn, AGR %)
Table 366. WuXi Biologics: Company Product and Service Benchmarking
Table 367. WuXi Biologics: Company Recent Developments till Feb,2021
Table 368. Serum Institute of India: Company Information
Table 369. Serum Institute of India: Company Product and Service Benchmarking
Table 370. Serum Institute of India: Company Recent Developments
Table 371. Richter-Helm BioLogics: Company Information
Table 372. Richter-Helm BioLogics: Company Product and Service Benchmarking
Table 373. Richter-Helm BioLogics: Company Recent Developments
Table 374. Wacker Biotech B.V: Company Information
Table 375. Wacker Biotech B.V: Company Product and Service Benchmarking
Table 376. Kemwell Biopharma: Company Information
Table 377. Kemwell Biopharma: Company Product and Service Benchmarking

List of Figures
Figure 1. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 2. Global Vaccine Contract Manufacturing Market Segmentation
Figure 3. Global Vaccine Contract Manufacturing Market Trends :
Figure 4. Porter’s Five Forces Analysis of Vaccine Contract Manufacturing Market
Figure 5. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 6. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 7. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 8. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 9. Global Vaccine Contract Manufacturing Market by Value, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 10. Global Vaccine Contract Manufacturing Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 11. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 12. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (V - Shaped Recovery)
Figure 13. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (W - Shaped Recovery)
Figure 14. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (U - Shaped Recovery)
Figure 15. Global Vaccine Contract Manufacturing Market by Region, 2021-2031 (USD Mn, AGR (%), CAGR(%)) (L - Shaped Recovery)
Figure 16. Global Vaccine Contract Manufacturing Market Share Forecast by Process 2022, 2027, 2032(%)
Figure 17. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 18. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 19. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 20. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 21. Global Vaccine Contract Manufacturing Market by Process, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 22. Global Vaccine Contract Manufacturing Market Share Forecast by Downstream 2022, 2027, 2032(%)
Figure 23. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 24. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 25. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 26. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 27. Global Vaccine Contract Manufacturing Market by Downstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 28. Global Vaccine Contract Manufacturing Market Share Forecast by Upstream 2022, 2027, 2032(%)
Figure 29. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 30. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 31. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 32. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 33. Global Vaccine Contract Manufacturing Market by Upstream, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 34. Global Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type 2022, 2027, 2032(%)
Figure 35. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 36. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 37. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 38. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 39. Global Vaccine Contract Manufacturing Market by Vaccine Type, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 40. Global Vaccine Contract Manufacturing Market Share Forecast by Company Size 2022, 2027, 2032(%)
Figure 41. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 42. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 43. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 44. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 45. Global Vaccine Contract Manufacturing Market by Company Size, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 46. Global Vaccine Contract Manufacturing Market Share Forecast by Operation 2022, 2027, 2032(%)
Figure 47. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%))
Figure 48. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 49. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 50. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 51. Global Vaccine Contract Manufacturing Market by Operation, 2021-2031 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 52. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 53. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 54. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 55. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 56. North America Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 57. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 58. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 59. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 60. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 61. North America Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 62. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 63. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 64. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 65. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 66. North America Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 67. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 68. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 69. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 70. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 71. North America Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 72. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 73. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 74. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 75. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 76. North America Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 77. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 78. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 79. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 80. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 81. North America Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 82. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 83. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 84. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 85. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 86. North America Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 87. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 88. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 89. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 90. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 91. North America Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 92. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 93. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 94. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 95. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 96. US Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 97. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 98. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 99. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 100. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 101. Canada Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 102. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 103. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 104. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 105. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 106. Mexico Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 107. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 108. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 109. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 110. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 111. Europe Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 112. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 113. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 114. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 115. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 116. Europe Vaccine Contract Manufacturing Market by Country, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 117. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 118. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 119. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 120. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 121. Europe Vaccine Contract Manufacturing Market by Process, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 122. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 123. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 124. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 125. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 126. Europe Vaccine Contract Manufacturing Market by Downstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 127. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 128. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 129. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 130. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 131. Europe Vaccine Contract Manufacturing Market by Upstream, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 132. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 133. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 134. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 135. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 136. Europe Vaccine Contract Manufacturing Market by Vaccine Type, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 137. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 138. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 139. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 140. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 141. Europe Vaccine Contract Manufacturing Market by Company Size, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 142. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 143. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 144. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shaped Recovery)
Figure 145. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (U - Shaped Recovery)
Figure 146. Europe Vaccine Contract Manufacturing Market by Operation, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (L - Shaped Recovery)
Figure 147. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 148. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (V - Shaped Recovery)
Figure 149. Germany Vaccine Contract Manufacturing Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR (%)) (W - Shape

お買い物ガイド
よくある質問

この商品のレポートナンバー

0000031856

会員登録
TOP